May 7, 2020 / 12:21 PM / a month ago

BRIEF-Rising Pharmaceuticals & Laurus Labs To Support A Phase 2 Clinical Trial Of Hydroxychloroquine For Prophylaxis Against Covid-19 In Patients Receiving Cancer Therapy

May 7 (Reuters) -

* RISING PHARMACEUTICALS & LAURUS LABS TO SUPPORT A PHASE 2 RANDOMIZED CLINICAL TRIAL OF HYDROXYCHLOROQUINE FOR PROPHYLAXIS AGAINST COVID-19 IN PATIENTS RECEIVING CANCER THERAPY Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below